New Day Diagnostics Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
New Day Diagnostics General Information
Description
Developer of non-invasive diagnostic tests designed to improve the detection of diseases. The company passionately serves and collaborates with healthcare professionals, the scientific community, and consumers alike by providing accurate, fast, and easy-to-use diagnostic tests that enable the early detection of a broad spectrum of diseases, helping health systems enhance the care they deliver with efficient and accurate tools.
Contact Information
Website
www.newdaydiagnostics.comCorporate Office
- 6701 Baum Drive
- Suite 110
- Knoxville, TN 37919
- United States
Corporate Office
- 6701 Baum Drive
- Suite 110
- Knoxville, TN 37919
- United States
New Day Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 06-Mar-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 30-Jun-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 15-Aug-2023 | Cancelled | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jun-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 18-Aug-2016 | $82.5K | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 29-Jul-2016 | $82.5K | $82.5K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
New Day Diagnostics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
New Day Diagnostics Patents
New Day Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250129427-A1 | Improved methods for detecting colorectal cancer | Pending | 09-Aug-2021 | ||
| US-20230287509-A1 | Methods for detecting liver cancer | Pending | 21-Jul-2020 | ||
| US-20220403473-A1 | Methods for detecting colorectal cancer | Pending | 16-Dec-2019 | ||
| AU-2020406068-A1 | Methods for detecting colorectal cancer | Pending | 16-Dec-2019 | ||
| EP-3817756-A2 | Bcl-2 antibodies and immunoassay for diagnosis of cancer | Pending | 05-Jul-2018 | C07K16/28 |
New Day Diagnostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
New Day Diagnostics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Launch Tennessee | Not-For-Profit Venture Capital | Minority | ||
| TCB Capital Advisors | Merchant Banking Firm | Minority | ||
| Tampa Bay Technology Incubator | Accelerator/Incubator | Minority | ||
| Boma Investments | Impact Investing | Minority | ||
| Institute for Commercialization of Florida Technology | Not-For-Profit Venture Capital | Minority |
New Day Diagnostics Acquisitions (2)
New Day Diagnostics’s most recent deal was a Merger/Acquisition with Epigenomics for . The deal was made on 24-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Epigenomics | 24-Jul-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| EDP Biotech | 05-Jul-2023 | Merger/Acquisition | Diagnostic Equipment |
New Day Diagnostics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Epigenomics | Berlin, Germany | 1998 |
New Day Diagnostics FAQs
-
When was New Day Diagnostics founded?
New Day Diagnostics was founded in 2005.
-
Where is New Day Diagnostics headquartered?
New Day Diagnostics is headquartered in Knoxville, TN.
-
What is the size of New Day Diagnostics?
New Day Diagnostics has 24 total employees.
-
What industry is New Day Diagnostics in?
New Day Diagnostics’s primary industry is Diagnostic Equipment.
-
Is New Day Diagnostics a private or public company?
New Day Diagnostics is a Private company.
-
What is New Day Diagnostics’s current revenue?
The current revenue for New Day Diagnostics is .
-
How much funding has New Day Diagnostics raised over time?
New Day Diagnostics has raised $82.5K.
-
Who are New Day Diagnostics’s investors?
Launch Tennessee, TCB Capital Advisors, Tampa Bay Technology Incubator, Boma Investments, and Institute for Commercialization of Florida Technology are 5 of 6 investors who have invested in New Day Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
